Research Directory

New era for drug pricing in US

Read more

Checkpoint inhibitors are focus at ESMO

Read more

Biotech companies advised to conserve cash

Read more

Viable malaria vaccine moves a step closer

Read more

Microbiome-based therapies as anti-cancer agents

Read more

Direct cell reprogramming: Mogrify and Astellas to address hearing loss

Read more

Antibody-drug conjugates come to the fore

Read more

The microbiome and cancer

Read more

The lasting value of small molecule drugs

Read more

Investigating a functional cure for hepatitis B

Read more